The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

University Of Rochester competitive analysis

Loading summary...

Latest patents of University Of Rochester opposed by its competitors

Explore University Of Rochester's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3636778
Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP3192880
Oct 9, 2019Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP3031920
Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression1

Latest PTAB cases involving University Of Rochester

Discover the latest PTAB cases involving University Of Rochester, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving University Of Rochester

IPR2013-00320May 31, 2013CARDIOCOMUNIVERSITY OF ROCHESTERTerminated-Settled

Peer Comparison New

IP litigation analysis comparing University Of Rochester with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSITY OF ROCHESTER - 5 - 1
CARDIOCOM - - 8 -
CMS CAMERON MCKENNA NABARRO OLSWANG11 - - -
STRAWMAN339 - - -